ID   TTC7A_HUMAN             Reviewed;         858 AA.
AC   Q9ULT0; Q2T9J9; Q6PIX4; Q8ND67; Q9BUS3;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 3.
DT   28-JUN-2023, entry version 191.
DE   RecName: Full=Tetratricopeptide repeat protein 7A {ECO:0000305};
DE            Short=TPR repeat protein 7A {ECO:0000305};
GN   Name=TTC7A {ECO:0000312|HGNC:HGNC:19750};
GN   Synonyms=KIAA1140 {ECO:0000303|PubMed:10574461}, TTC7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT LEU-538.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 82-858 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis from
RT   size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 409-858 (ISOFORM 1).
RC   TISSUE=Cervix, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51 AND SER-182, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51 AND SER-647, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   FUNCTION.
RX   PubMed=23229899; DOI=10.1083/jcb.201206095;
RA   Nakatsu F., Baskin J.M., Chung J., Tanner L.B., Shui G., Lee S.Y.,
RA   Pirruccello M., Hao M., Ingolia N.T., Wenk M.R., De Camilli P.;
RT   "PtdIns4P synthesis by PI4KIIIalpha at the plasma membrane and its impact
RT   on plasma membrane identity.";
RL   J. Cell Biol. 199:1003-1016(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51; SER-182; SER-647; SER-690
RP   AND THR-693, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-647 AND THR-693, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   INVOLVEMENT IN GIDID1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=25546680; DOI=10.1097/md.0000000000000327;
RA   Fernandez I., Patey N., Marchand V., Birlea M., Maranda B., Haddad E.,
RA   Decaluwe H., Le Deist F.;
RT   "Multiple intestinal atresia with combined immune deficiency related to
RT   TTC7A defect is a multiorgan pathology: study of a French-Canadian-based
RT   cohort.";
RL   Medicine (Baltimore) 93:E327-E327(2014).
RN   [15]
RP   INTERACTION WITH PI4KA.
RX   PubMed=34415310; DOI=10.1093/brain/awab313;
RA   Salter C.G., Cai Y., Lo B., Helman G., Taylor H., McCartney A.,
RA   Leslie J.S., Accogli A., Zara F., Traverso M., Fasham J., Lees J.A.,
RA   Ferla M.P., Chioza B.A., Wenger O., Scott E., Cross H.E., Crawford J.,
RA   Warshawsky I., Keisling M., Agamanolis D., Ward Melver C., Cox H.,
RA   Elawad M., Marton T., Wakeling M.N., Holzinger D., Tippelt S., Munteanu M.,
RA   Valcheva D., Deal C., Van Meerbeke S., Walsh Vockley C., Butte M.J.,
RA   Acar U., van der Knaap M.S., Korenke G.C., Kotzaeridou U., Balla T.,
RA   Simons C., Uhlig H.H., Crosby A.H., De Camilli P., Wolf N.I., Baple E.L.;
RT   "Biallelic PI4KA variants cause neurological, intestinal and immunological
RT   disease.";
RL   Brain 144:3597-3610(2021).
RN   [16]
RP   VARIANTS GIDID1 PRO-399; ARG-606; PRO-672; SER-678 DEL; GLN-712 DEL AND
RP   PRO-823.
RX   PubMed=23830146; DOI=10.1016/j.jaci.2013.06.013;
RA   Chen R., Giliani S., Lanzi G., Mias G.I., Lonardi S., Dobbs K., Manis J.,
RA   Im H., Gallagher J.E., Phanstiel D.H., Euskirchen G., Lacroute P.,
RA   Bettinger K., Moratto D., Weinacht K., Montin D., Gallo E., Mangili G.,
RA   Porta F., Notarangelo L.D., Pedretti S., Al-Herz W., Alfahdli W.,
RA   Comeau A.M., Traister R.S., Pai S.Y., Carella G., Facchetti F.,
RA   Nadeau K.C., Snyder M., Notarangelo L.D.;
RT   "Whole-exome sequencing identifies tetratricopeptide repeat domain 7A
RT   (TTC7A) mutations for combined immunodeficiency with intestinal atresias.";
RL   J. Allergy Clin. Immunol. 132:656-664(2013).
RN   [17]
RP   VARIANT GIDID1 PRO-823.
RX   PubMed=23423984; DOI=10.1136/jmedgenet-2012-101483;
RA   Samuels M.E., Majewski J., Alirezaie N., Fernandez I., Casals F., Patey N.,
RA   Decaluwe H., Gosselin I., Haddad E., Hodgkinson A., Idaghdour Y.,
RA   Marchand V., Michaud J.L., Rodrigue M.A., Desjardins S., Dubois S.,
RA   Le Deist F., Awadalla P., Raymond V., Maranda B.;
RT   "Exome sequencing identifies mutations in the gene TTC7A in French-Canadian
RT   cases with hereditary multiple intestinal atresia.";
RL   J. Med. Genet. 50:324-329(2013).
RN   [18]
RP   VARIANTS GIDID1 LYS-71; GLN-526 DEL AND THR-832, CHARACTERIZATION OF
RP   VARIANTS GIDID1 LYS-71 AND THR-832, FUNCTION, AND INTERACTION WITH PI4KA.
RX   PubMed=24417819; DOI=10.1053/j.gastro.2014.01.015;
RA   Avitzur Y., Guo C., Mastropaolo L.A., Bahrami E., Chen H., Zhao Z.,
RA   Elkadri A., Dhillon S., Murchie R., Fattouh R., Huynh H., Walker J.L.,
RA   Wales P.W., Cutz E., Kakuta Y., Dudley J., Kammermeier J., Powrie F.,
RA   Shah N., Walz C., Nathrath M., Kotlarz D., Puchaka J., Krieger J.R.,
RA   Racek T., Kirchner T., Walters T.D., Brumell J.H., Griffiths A.M.,
RA   Rezaei N., Rashtian P., Najafi M., Monajemzadeh M., Pelsue S.,
RA   McGovern D.P., Uhlig H.H., Schadt E., Klein C., Snapper S.B., Muise A.M.;
RT   "Mutations in tetratricopeptide repeat domain 7A result in a severe form of
RT   very early onset inflammatory bowel disease.";
RL   Gastroenterology 146:1028-1039(2014).
RN   [19]
RP   VARIANTS GIDID1 ASP-551 AND GLN-828 DEL.
RX   PubMed=24931897; DOI=10.1007/s10875-014-0067-7;
RA   Agarwal N.S., Northrop L., Anyane-Yeboa K., Aggarwal V.S., Nagy P.L.,
RA   Demirdag Y.Y.;
RT   "Tetratricopeptide repeat domain 7A (TTC7A) mutation in a newborn with
RT   multiple intestinal atresia and combined immunodeficiency.";
RL   J. Clin. Immunol. 34:607-610(2014).
RN   [20]
RP   VARIANTS GIDID1 GLN-277 DEL; TYR-336 DEL; LEU-539 AND ALA-832 DEL.
RX   PubMed=24292712; DOI=10.1172/jci71471;
RA   Bigorgne A.E., Farin H.F., Lemoine R., Mahlaoui N., Lambert N., Gil M.,
RA   Schulz A., Philippet P., Schlesser P., Abrahamsen T.G., Oymar K.,
RA   Davies E.G., Ellingsen C.L., Leteurtre E., Moreau-Massart B., Berrebi D.,
RA   Bole-Feysot C., Nischke P., Brousse N., Fischer A., Clevers H.,
RA   de Saint Basile G.;
RT   "TTC7A mutations disrupt intestinal epithelial apicobasal polarity.";
RL   J. Clin. Invest. 124:328-337(2014).
RN   [21]
RP   VARIANT GIDID1 PRO-346.
RX   PubMed=25745186; DOI=10.1182/blood-2014-08-595397;
RA   Woutsas S., Aytekin C., Salzer E., Conde C.D., Apaydin S., Pichler H.,
RA   Memaran-Dadgar N., Hosnut F.O., Foerster-Waldl E., Matthes S., Huber W.D.,
RA   Lion T., Holter W., Bilic I., Boztug K.;
RT   "Hypomorphic mutation in TTC7A causes combined immunodeficiency with mild
RT   structural intestinal defects.";
RL   Blood 125:1674-1676(2015).
RN   [22]
RP   VARIANT GIDID1 GLU-857 DEL.
RX   PubMed=25534311; DOI=10.1111/cge.12553;
RA   Yang W., Lee P.P., Thong M.K., Ramanujam T.M., Shanmugam A., Koh M.T.,
RA   Chan K.W., Ying D., Wang Y., Shen J.J., Yang J., Lau Y.L.;
RT   "Compound heterozygous mutations in TTC7A cause familial multiple
RT   intestinal atresias and severe combined immunodeficiency.";
RL   Clin. Genet. 88:542-549(2015).
CC   -!- FUNCTION: Component of a complex required to localize
CC       phosphatidylinositol 4-kinase (PI4K) to the plasma membrane
CC       (PubMed:23229899, PubMed:24417819). The complex acts as a regulator of
CC       phosphatidylinositol 4-phosphate (PtdIns(4)P) synthesis (Probable). In
CC       the complex, plays a central role in bridging PI4KA to EFR3B and HYCC1,
CC       via direct interactions (By similarity). {ECO:0000250|UniProtKB:Q86TV6,
CC       ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:24417819}.
CC   -!- SUBUNIT: Component of a phosphatidylinositol 4-kinase (PI4K) complex,
CC       composed of PI4KA, EFR3 (EFR3A or EFR3B), TTC7 (TTC7A or TTC7B) and
CC       HYCC (HYCC1 or HYCC2) (PubMed:24417819). Interacts with PI4KA
CC       (PubMed:34415310). Interaction with PI4KA is direct (By similarity).
CC       Interacts with EFR3 (EFR3A or EFR3B), interaction is direct (By
CC       similarity). Interacts with HYCC (HYCC1 or HYCC2), interaction is
CC       direct (By similarity). Association with the PI4K complex is strongly
CC       reduced by TMEM150A (By similarity). {ECO:0000250|UniProtKB:Q86TV6,
CC       ECO:0000269|PubMed:24417819, ECO:0000269|PubMed:34415310}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:25546680}. Cell
CC       membrane {ECO:0000250|UniProtKB:Q86TV6}. Note=Localizes to the cytosol
CC       and is recruited to the plasma membrane following interaction with EFR3
CC       (EFR3A or EFR3B). {ECO:0000250|UniProtKB:Q86TV6}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9ULT0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9ULT0-3; Sequence=VSP_039347, VSP_039348;
CC       Name=3;
CC         IsoId=Q9ULT0-4; Sequence=VSP_057271;
CC   -!- TISSUE SPECIFICITY: Expressed in epithelial cells of the intestine,
CC       thymus, and pancreas (at protein level). {ECO:0000269|PubMed:25546680}.
CC   -!- DISEASE: Gastrointestinal defects and immunodeficiency syndrome 1
CC       (GIDID1) [MIM:243150]: An autosomal recessive congenital disorder in
CC       which obstructions occur at various levels throughout the small and
CC       large intestines, ultimately leading to organ failure. Surgical
CC       interventions are palliative but do not provide long-term survival.
CC       Some patients exhibit inflammatory bowel disease (IBD), with or without
CC       intestinal atresia, and in some cases, the intestinal features are
CC       associated with either mild or severe combined immunodeficiency.
CC       {ECO:0000269|PubMed:23423984, ECO:0000269|PubMed:23830146,
CC       ECO:0000269|PubMed:24292712, ECO:0000269|PubMed:24417819,
CC       ECO:0000269|PubMed:24931897, ECO:0000269|PubMed:25534311,
CC       ECO:0000269|PubMed:25546680, ECO:0000269|PubMed:25745186}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry. Phenotypic variations have been observed: the mildest case show
CC       intestinal aberrations consisting of bloody diarrhea, apoptotic
CC       enterocolitis, and acute graft-versus-host disease- (GVHD)-like
CC       symptoms, but no atresias (PubMed:25546680). Other patients show
CC       multiple intestinal atresias, some being associated with
CC       immunodeficiency syndrome, while other do not show immunodeficiency
CC       defects (PubMed:23423984). {ECO:0000269|PubMed:23423984,
CC       ECO:0000269|PubMed:25546680}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86454.2; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL834383; CAD39046.2; -; mRNA.
DR   EMBL; AB032966; BAA86454.2; ALT_SEQ; mRNA.
DR   EMBL; AC016722; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073283; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093732; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001978; AAH01978.1; -; mRNA.
DR   EMBL; BC027457; AAH27457.1; -; mRNA.
DR   EMBL; BC111487; AAI11488.1; -; mRNA.
DR   CCDS; CCDS33193.1; -. [Q9ULT0-1]
DR   CCDS; CCDS74511.1; -. [Q9ULT0-4]
DR   RefSeq; NP_001275880.1; NM_001288951.1. [Q9ULT0-4]
DR   RefSeq; NP_001275882.1; NM_001288953.1.
DR   RefSeq; NP_001275884.1; NM_001288955.1.
DR   RefSeq; NP_065191.2; NM_020458.3. [Q9ULT0-1]
DR   AlphaFoldDB; Q9ULT0; -.
DR   SMR; Q9ULT0; -.
DR   BioGRID; 121455; 25.
DR   IntAct; Q9ULT0; 8.
DR   MINT; Q9ULT0; -.
DR   STRING; 9606.ENSP00000378320; -.
DR   GlyGen; Q9ULT0; 1 site.
DR   iPTMnet; Q9ULT0; -.
DR   PhosphoSitePlus; Q9ULT0; -.
DR   BioMuta; TTC7A; -.
DR   DMDM; 34223742; -.
DR   EPD; Q9ULT0; -.
DR   jPOST; Q9ULT0; -.
DR   MassIVE; Q9ULT0; -.
DR   MaxQB; Q9ULT0; -.
DR   PaxDb; Q9ULT0; -.
DR   PeptideAtlas; Q9ULT0; -.
DR   ProteomicsDB; 61446; -.
DR   ProteomicsDB; 85104; -. [Q9ULT0-1]
DR   ProteomicsDB; 85105; -. [Q9ULT0-3]
DR   Antibodypedia; 47406; 120 antibodies from 21 providers.
DR   DNASU; 57217; -.
DR   Ensembl; ENST00000319190.11; ENSP00000316699.5; ENSG00000068724.18. [Q9ULT0-1]
DR   Ensembl; ENST00000394850.6; ENSP00000378320.2; ENSG00000068724.18. [Q9ULT0-4]
DR   GeneID; 57217; -.
DR   KEGG; hsa:57217; -.
DR   MANE-Select; ENST00000319190.11; ENSP00000316699.5; NM_020458.4; NP_065191.2.
DR   UCSC; uc002rvo.4; human. [Q9ULT0-1]
DR   AGR; HGNC:19750; -.
DR   CTD; 57217; -.
DR   DisGeNET; 57217; -.
DR   GeneCards; TTC7A; -.
DR   HGNC; HGNC:19750; TTC7A.
DR   HPA; ENSG00000068724; Tissue enhanced (testis).
DR   MalaCards; TTC7A; -.
DR   MIM; 243150; phenotype.
DR   MIM; 609332; gene.
DR   neXtProt; NX_Q9ULT0; -.
DR   OpenTargets; ENSG00000068724; -.
DR   Orphanet; 436252; Combined immunodeficiency-enteropathy spectrum.
DR   Orphanet; 2300; Multiple intestinal atresia.
DR   PharmGKB; PA134993362; -.
DR   VEuPathDB; HostDB:ENSG00000068724; -.
DR   eggNOG; KOG4162; Eukaryota.
DR   GeneTree; ENSGT00940000158638; -.
DR   HOGENOM; CLU_010512_1_0_1; -.
DR   InParanoid; Q9ULT0; -.
DR   OMA; WYRRIMT; -.
DR   OrthoDB; 25200at2759; -.
DR   PhylomeDB; Q9ULT0; -.
DR   TreeFam; TF313783; -.
DR   PathwayCommons; Q9ULT0; -.
DR   SignaLink; Q9ULT0; -.
DR   BioGRID-ORCS; 57217; 85 hits in 1158 CRISPR screens.
DR   ChiTaRS; TTC7A; human.
DR   GenomeRNAi; 57217; -.
DR   Pharos; Q9ULT0; Tbio.
DR   PRO; PR:Q9ULT0; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9ULT0; protein.
DR   Bgee; ENSG00000068724; Expressed in sperm and 165 other tissues.
DR   ExpressionAtlas; Q9ULT0; baseline and differential.
DR   Genevisible; Q9ULT0; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0030097; P:hemopoiesis; IEA:Ensembl.
DR   GO; GO:0006879; P:intracellular iron ion homeostasis; IEA:Ensembl.
DR   GO; GO:0046854; P:phosphatidylinositol phosphate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB.
DR   Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 2.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_repeat.
DR   InterPro; IPR045819; TTC7_N.
DR   PANTHER; PTHR23083:SF475; TETRATRICOPEPTIDE REPEAT PROTEIN 7A; 1.
DR   PANTHER; PTHR23083; TETRATRICOPEPTIDE REPEAT PROTEIN, TPR; 1.
DR   Pfam; PF13181; TPR_8; 2.
DR   Pfam; PF19440; TTC7_N; 1.
DR   SMART; SM00028; TPR; 7.
DR   SUPFAM; SSF48452; TPR-like; 2.
DR   PROSITE; PS50005; TPR; 8.
DR   PROSITE; PS50293; TPR_REGION; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cytoplasm; Disease variant; Membrane;
KW   Phosphoprotein; Reference proteome; Repeat; TPR repeat.
FT   CHAIN           1..858
FT                   /note="Tetratricopeptide repeat protein 7A"
FT                   /id="PRO_0000106385"
FT   REPEAT          121..157
FT                   /note="TPR 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          177..210
FT                   /note="TPR 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          414..447
FT                   /note="TPR 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          497..531
FT                   /note="TPR 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          533..565
FT                   /note="TPR 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          566..599
FT                   /note="TPR 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          745..778
FT                   /note="TPR 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          780..812
FT                   /note="TPR 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          813..846
FT                   /note="TPR 9"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         51
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         182
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         647
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         678
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BGB2"
FT   MOD_RES         679
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BGB2"
FT   MOD_RES         690
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         693
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         117..146
FT                   /note="PQYMCEAMLILGKLHYVEGSYRDAISMYAR -> GLAVLLRLVSNSWAQAIL
FT                   LLQPPEALGLQE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10574461"
FT                   /id="VSP_039347"
FT   VAR_SEQ         147..858
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10574461"
FT                   /id="VSP_039348"
FT   VAR_SEQ         639
FT                   /note="L -> LGDFRSPEGFQTPQRNICNSEIYRG (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_057271"
FT   VARIANT         71
FT                   /note="E -> K (in GIDID1; reduced interaction with PI4KA;
FT                   dbSNP:rs147914967)"
FT                   /evidence="ECO:0000269|PubMed:24417819"
FT                   /id="VAR_075126"
FT   VARIANT         277
FT                   /note="Missing (in GIDID1)"
FT                   /evidence="ECO:0000269|PubMed:24292712"
FT                   /id="VAR_075127"
FT   VARIANT         336
FT                   /note="Missing (in GIDID1)"
FT                   /evidence="ECO:0000269|PubMed:24292712"
FT                   /id="VAR_075128"
FT   VARIANT         346
FT                   /note="L -> P (in GIDID1)"
FT                   /evidence="ECO:0000269|PubMed:25745186"
FT                   /id="VAR_075129"
FT   VARIANT         399
FT                   /note="L -> P (in GIDID1)"
FT                   /evidence="ECO:0000269|PubMed:23830146"
FT                   /id="VAR_075130"
FT   VARIANT         526
FT                   /note="Missing (in GIDID1)"
FT                   /evidence="ECO:0000269|PubMed:24417819"
FT                   /id="VAR_075131"
FT   VARIANT         538
FT                   /note="V -> L (in dbSNP:rs2304290)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_016602"
FT   VARIANT         539
FT                   /note="S -> L (in GIDID1; dbSNP:rs776906926)"
FT                   /evidence="ECO:0000269|PubMed:24292712"
FT                   /id="VAR_075132"
FT   VARIANT         545
FT                   /note="V -> I (in dbSNP:rs6755258)"
FT                   /id="VAR_052624"
FT   VARIANT         551
FT                   /note="A -> D (in GIDID1)"
FT                   /evidence="ECO:0000269|PubMed:24931897"
FT                   /id="VAR_075133"
FT   VARIANT         606
FT                   /note="K -> R (in GIDID1; dbSNP:rs139010200)"
FT                   /evidence="ECO:0000269|PubMed:23830146"
FT                   /id="VAR_075134"
FT   VARIANT         672
FT                   /note="S -> P (in GIDID1; dbSNP:rs149602485)"
FT                   /evidence="ECO:0000269|PubMed:23830146"
FT                   /id="VAR_075135"
FT   VARIANT         678
FT                   /note="Missing (in GIDID1)"
FT                   /evidence="ECO:0000269|PubMed:23830146"
FT                   /id="VAR_075136"
FT   VARIANT         712
FT                   /note="Missing (in GIDID1)"
FT                   /evidence="ECO:0000269|PubMed:23830146"
FT                   /id="VAR_075137"
FT   VARIANT         823
FT                   /note="L -> P (in GIDID1; dbSNP:rs587776972)"
FT                   /evidence="ECO:0000269|PubMed:23423984,
FT                   ECO:0000269|PubMed:23830146"
FT                   /id="VAR_069636"
FT   VARIANT         828
FT                   /note="Missing (in GIDID1)"
FT                   /evidence="ECO:0000269|PubMed:24931897"
FT                   /id="VAR_075138"
FT   VARIANT         832
FT                   /note="A -> T (in GIDID1; reduced interaction with PI4KA;
FT                   dbSNP:rs876657393)"
FT                   /evidence="ECO:0000269|PubMed:24417819"
FT                   /id="VAR_075139"
FT   VARIANT         832
FT                   /note="Missing (in GIDID1)"
FT                   /evidence="ECO:0000269|PubMed:24292712"
FT                   /id="VAR_075140"
FT   VARIANT         857
FT                   /note="Missing (in GIDID1)"
FT                   /evidence="ECO:0000269|PubMed:25534311"
FT                   /id="VAR_075141"
FT   CONFLICT        603
FT                   /note="M -> I (in Ref. 2; BAA86454)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   858 AA;  96185 MW;  9D10411B48478171 CRC64;
     MAAKGAHGSY LKVESELERC RAEGHWDRMP ELVRQLQTLS MPGGGGNRRG SPSAAFTFPD
     TDDFGKLLLA EALLEQCLKE NHAKIKDSMP LLEKNEPKMS EAKNYLSSIL NHGRLSPQYM
     CEAMLILGKL HYVEGSYRDA ISMYARAGID DMSMENKPLY QMRLLSEAFV IKGLSLERLP
     NSIASRFRLT EREEEVITCF ERASWIAQVF LQELEKTTNN STSRHLKGCH PLDYELTYFL
     EAALQSAYVK NLKKGNIVKG MRELREVLRT VETKATQNFK VMAAKHLAGV LLHSLSEECY
     WSPLSHPLPE FMGKEESSFA TQALRKPHLY EGDNLYCPKD NIEEALLLLL ISESMATRDV
     VLSRVPEQEE DRTVSLQNAA AIYDLLSITL GRRGQYVMLS ECLERAMKFA FGEFHLWYQV
     ALSMVACGKS AYAVSLLREC VKLRPSDPTV PLMAAKVCIG SLRWLEEAEH FAMMVISLGE
     EAGEFLPKGY LALGLTYSLQ ATDATLKSKQ DELHRKALQT LERAQQLAPS DPQVILYVSL
     QLALVRQISS AMEQLQEALK VRKDDAHALH LLALLFSAQK HHQHALDVVN MAITEHPENF
     NLMFTKVKLE QVLKGPEEAL VTCRQVLRLW QTLYSFSQLG GLEKDGSFGE GLTMKKQSGM
     HLTLPDAHDA DSGSRRASSI AASRLEEAMS ELTMPSSVLK QGPMQLWTTL EQIWLQAAEL
     FMEQQHLKEA GFCIQEAAGL FPTSHSVLYM RGRLAEVKGN LEEAKQLYKE ALTVNPDGVR
     IMHSLGLMLS RLGHKSLAQK VLRDAVERQS TCHEAWQGLG EVLQAQGQNE AAVDCFLTAL
     ELEASSPVLP FSIIPREL
//
